This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Compounding Pharmacy Compliance

$400 Savings Ends in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
June 9-10, 2026
Hilton Philadelphia at Penn's LandingPhiladelphia, PA

Victor Hill
Director of Quality at Vios Compounding
Speaker

Profile

Victor Hill is the Director of Quality at a 503A Compounding Pharmacy. With a background as a Biochemist, he applies a rigorous, science-based approach to compliance and formulation design.

Victor is a specialist in pharmaceutical quality systems, including adherence to USP General Chapters <795>, <797>, and <800>. He has driven the launch and ongoing quality control for the pharmacy’s GLP-1 offerings, including semaglutide and tirzepatide. His work includes overseeing API sourcing, Certificate of Analysis (CoA) reviews, and leading the R&D efforts that have resulted in formulation improvements for stability and efficacy.

In this session, Victor will detail best practices for the GLP-1 Compliance Workshop, guiding attendees through critical topics such as: establishing protocols for dosing accuracy, validating cold-chain shipping to protect drug potency, and utilizing quality systems to ensure product consistency and reduce compliance risk.

Agenda Sessions

  • 503B Regulatory Update and Evolving FDA Focus: Strengthening Oversight and Operational Readiness

    9:00am
  • Peptide Innovation: Exploring Semerollin, Gondarellin, and Next-Gen 503B Compounding

    11:00am